Plain-English coverage of GLP-1 weight-loss medications: the latest FDA updates, what each treatment really costs, and how to choose a program.
Ready to pick one? Take the 2-minute match quiz or see the cheapest options.
Updated August 5, 2026: Added Lilly's ClinicalTrials.gov expanded-access record (NCT07629401), registered June 5, 2026, which lists no eligibility criteria. Biologic classification lawsuit context (Lilly v. FDA, Case 1:24-cv-01503). Obesity (TRIUMPH-1): 28.3% weight loss at 80 we…
Serena Williams disclosed GLP-1 treatment and a commercial Ro relationship in 2025, then returned to professional tennis in 2026. No cited o…
A Penn-led analysis compared seven cardiometabolic outcomes across GLP-1 trial programs, while Mayo researchers identified a possible obesit…
Neither the Wegovy nor the Zepbound prescribing information mentions alcohol. This is what the labels do say about hypoglycemia and nausea, …
Berberine picked up the nickname "nature's Ozempic" on TikTok. The two compounds act on different targets, and the meta-analysis that looked…
What the Ozempic, Wegovy, Mounjaro and Zepbound labels actually say about the fridge, the counter, a hot car, a freezer, and an airport chec…
Every legal route to semaglutide runs through a licensed prescriber and a licensed pharmacy. This is the decision tree: how legitimate teleh…
A weight plateau on semaglutide or tirzepatide has four separate causes, and they do not share an answer. Here is how to tell which one you …
Clinical trials show 14.9-20.7% body weight loss with semaglutide depending on dose. Standard Wegovy (2.4mg): 14.9-17% over 68 weeks. Wegovy…
Updated August 14, 2026: Oral Wegovy produced 16.6% weight loss in OASIS vs Foundayo's 12.4% in ATTAIN-1; these were separate trials. Both m…
Updated July 2026: Tirzepatide produces 20.2% weight loss vs semaglutide's 13.7% in the SURMOUNT-5 head-to-head trial (NEJM 2024): a 47% gre…
As of August 2026, two FDA-approved oral GLP-1 weight-loss pills exist: Foundayo (orforglipron, 12.4% in ATTAIN-1, LillyDirect from $149/mo …
Updated August 2026: SURMOUNT-5 head-to-head trial (NEJM): Zepbound 20.2% vs Wegovy 13.7% weight loss at 72 weeks. Wegovy HD (7.2mg, FDA-app…
How much do GLP-1 medications cost in 2026? Wegovy, Zepbound, Ozempic, Mounjaro & Foundayo range from $25 to $1,350/month. With insurance + …
Updated July 2026: Medicare Part D now covers Foundayo, Wegovy, and Zepbound for weight loss (live since July 1, 2026) via the Medicare GLP-…
Medicare GLP-1 coverage is NOW LIVE as of July 1, 2026. Here's who qualifies for the $50/month Bridge program, how to get prior auth, and wh…
Verified August 14, 2026: Ozempic and Wegovy are both semaglutide from Novo Nordisk. Ozempic ($1,027.51/mo list) is approved for type 2 diab…
Mounjaro (tirzepatide) and Ozempic (semaglutide) are both FDA-approved only for type 2 diabetes, neither is approved for weight loss (that's…
GLP-1 medications like Ozempic and Wegovy can help PCOS because the syndrome is driven by insulin resistance, and these drugs improve insuli…
FDA resolved the semaglutide shortage on February 21, 2025 and ended temporary shortage-based enforcement discretion on April 22 for 503A ph…
CagriSema (cagrilintide + semaglutide) lost 22.7% average body weight in adults with obesity (REDEFINE 1) and 13.7% in adults with type 2 di…
Updated June 11, 2026: CMS released the official prior authorization request form (cms.gov/glp-1-bridge.pdf, June 8) revealing a key eligibi…
IvyRx offers compounded semaglutide from $175/month and tirzepatide from $275/month with a rare flat-rate model, your price never increases …
Verified May 8, 2026, Updated August 12, 2026: On April 30, FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the list o…
Verified May 2026: Tirzepatide starts at 2.5 mg once weekly (non-therapeutic starter dose), escalates by 2.5 mg every 4 weeks to a maximum o…
Updated May 2026: 5 next-gen obesity drugs in Phase 3. Retatrutide (Lilly) 28.7% weight loss. CagriSema (Novo): REDEFINE-1 22.7% (obesity), …
Updated August 14, 2026: Foundayo (orforglipron) is Lilly's FDA-approved non-peptide GLP-1 pill. LillyDirect self-pay is $149 at 0.8 mg, $19…
Verified July 2026: Zepbound and Mounjaro are the exact same drug (tirzepatide) at the same doses. Mounjaro was FDA-approved May 2022 for Ty…
Verified July 2026: Zepbound (tirzepatide) side effects from the SURMOUNT clinical trials, nausea affects 24-29% of patients (vs 8% placebo)…
HHS Secretary Robert F. Kennedy Jr. is considering a regulatory framework for Medicare and Medicaid GLP-1 coverage, but only for patients wh…
FDA-approved GLP-1 receptor agonists for weight loss, 2026 guide. Eligibility: BMI 30+ (or 27+ with comorbidity). Semaglutide produces 14.9%…
Verified August 7, 2026: NovoCare lists the brand-name Wegovy pen at $199/mo for the first two low-dose fills, then $349/mo at standard stre…
Verified July 2026: GLP-1 patients lose 2-5 pounds in their first month. Appetite suppression starts week 1-2. Nausea peaks at week 4 dose e…
Verified August 2026: Oral Wegovy (25mg daily pill) produced 16.6% weight loss in OASIS vs 14.9% for injectable Wegovy (2.4mg weekly) in STE…
Verified July 2026: The 7 worst foods on Ozempic, Wegovy, Zepbound, fried food, sugary drinks, red meat portions, raw cruciferous veg, carbo…
Verified July 2026: 44% of Wegovy patients report nausea, 30% diarrhea, 24% vomiting in STEP-1 trial. Only 7% discontinued for side effects.…
Verified August 2026: Tirzepatide prices include $149/mo via Gala on a yearly microdose plan ($169/mo for 3 months), $299/mo via LillyDirect…
Tirzepatide's shortage was resolved in October 2024 and shortage-based enforcement discretion ended in early 2025. This guide compares adver…
Verified July 2026: Zepbound savings card cuts copay to $25/fill ($1,300 max annual savings) with commercial insurance. Mounjaro savings car…
Launch record updated August 14, 2026: Foundayo began shipping April 6. Its $649 figure is WAC/list price, not the current LillyDirect self-…
A source-bounded guide to FDA warning letters involving compounded GLP-1 marketing, labeling, and manufacturing. Our linked tracker is finit…
GLP-1 patches sold online don't contain semaglutide or tirzepatide, they're herbal supplements. Here's what the science says and what actual…
Two of the biggest telehealth platforms now offer branded Wegovy and GLP-1 programs. We compare Ro and Hims on pricing, medications, insuran…
The FDA just approved Eli Lilly's Foundayo (orforglipron), the only GLP-1 weight loss pill with no food, water, or timing restrictions. Here…
Four affiliate partners we feature, we may earn a commission.
Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. The objective ranking (by methodology score) and full methodology are at glp1picks.com/best.